Point-of-care testing

I can detect inflammatory markers.

Um, We look at Point of Care now, a wonderful company out of the West Coast, run by a CEO, Tina Saw, called Oral Genome.

We look at MMP8, we look at PG, and we look at salivary glucose, which informs us of these next tests that we're doing with the capillary blood testing.

So all of this is Point of Care.

So the hygiene room, imagine this, this is where patients come back two, three times a year, We could monitor them.

We can detect biomarkers and inflammation.